Skip to content

CELZ.OTC

Creative Medical Technology Holdings (CELZ.OTC) announced proof of concept studies to demonstrate the efficacy and use-value of their ImmCelz immunotherapy product for the treatment of rheumatoid arthritis today. Rheumatoid…